Skip to Content

Manzo Pharmaceuticals Inc MNZO Stock Quote

| Rating as of

PINX: MNZO

Market Closed

| Currency in USD

  • Last Close 0.00
  • Sector Financial Services
  • Industry Shell Companies
  • Investment Style
  • Day Range < 0.01  –  < 0.01
  • Year Range < 0.01  –  < 0.01
  • Market Cap 5.2454
  • Volume / Avg 2,000.0 /  2,000.0
  • Price / Sales
  • Price / Book
  • Forward Div Yield 1.25%
  • Trailing Div Yield

Morningstar‘s Stock Analysis MNZO

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics MNZO

Company Profile MNZO

Business Description

Manzo Pharmaceuticals Inc formerly known as Fortune Oil & Gas Inc manufactures and sells products and owns patents in the field of supplemental and holistic cures sold through retail and online distribution. The company also develops its lactose intolerance product, in which it holds an exclusive patent license. Its primary products are dietary supplements, probiotics and natural remedies. In addition tit also owns other products, including a remedy for babies suffering from colic and/or digestive gas. Geographically, operation of the group is functioned through United States.

Contact
2-6153 Main Street
Stouffville, ON, L4A 3R6, CAN
Industry Shell Companies
Employees

Competitors & Peers MNZO

Morningstar does not cover competitors or peers for this firm.

FAQs for Manzo Pharmaceuticals Inc Stock

No. MNZO does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

MNZO’s market cap is 5.25.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

MNZO’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare MNZO’s historical performance against its industry peers and the overall market.